Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H You

Showing results (321-330 of 352) with videos related to

Pageof 36
Sort By:
Respiration; International Review of Thoracic Diseases|February 27, 2001
Primary endobronchial leiomyosarcoma. Diagnosis following expectoration of tumor fragmentS H Lee, J J Shim, J S Shin, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|December 29, 2024
[The distributions of serum HBsAg level in chronic hepatitis B patients based on the China Registry of Hepatitis B (CR-HepB)]S Y Chen, S Shan, Y Y Kong, et al.
Molecular Endocrinology (Baltimore, Md.)|May 16, 2000
Involvement of JAK/STAT (Janus kinase/signal transducer and activator of transcription) in the thyrotropin signaling pathwayE S Park, H Kim, J M Suh, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|February 10, 2025
[Distribution characteristics of serum HBsAg levels in Chinese patients with chronic hepatitis B based on CR-HepB]S Y Chen, S Shan, Y Y Kong, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|August 29, 2022
[Analysis of change in esophageal varices and clinical characteristics in hepatitis B virus-related cirrhosis after antiviral therapy]B Q Wang, X N Wu, J L Zhou, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 27, 2009
CYP2C9*1B promoter polymorphisms, in linkage with CYP2C19*2, affect phenytoin autoinduction of clearance and maintenance doseAmarjit S Chaudhry, Thomas J Urban, Jatinder K Lamba, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|August 29, 2022
[Histological regression and clinical benefits in patients with liver cirrhosis after long-term anti-HBV treatment]S Y Chen, Y M Sun, J L Zhou, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|October 30, 2025
[Analysis of factors affecting fibrosis reversal in patients with metabolic associated steatohepatitis based on magnetic resonance elastography]Z Y Zhang, C L Sun, H Ren, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|January 12, 2018
[Qualitative pathological assessment of liver fibrosis regression after antiviral therapy in patients with chronic hepatitis B]Y M Sun, J L Zhou, L Wang, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|May 9, 2017
[Efficacy and safety of pegylated interferon α-2b injection (Y shape, 40 kD) in treatment of patients with genotype 1/6 chronic hepatitis C]B Feng, J Shang, S H Wu, et al.
Pageof 36

Showing results (321-330 of 352) with videos related to

Sort By:
Pageof 36
Respiration; International Review of Thoracic Diseases|February 27, 2001
Primary endobronchial leiomyosarcoma. Diagnosis following expectoration of tumor fragmentS H Lee, J J Shim, J S Shin, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|December 29, 2024
[The distributions of serum HBsAg level in chronic hepatitis B patients based on the China Registry of Hepatitis B (CR-HepB)]S Y Chen, S Shan, Y Y Kong, et al.
Molecular Endocrinology (Baltimore, Md.)|May 16, 2000
Involvement of JAK/STAT (Janus kinase/signal transducer and activator of transcription) in the thyrotropin signaling pathwayE S Park, H Kim, J M Suh, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|February 10, 2025
[Distribution characteristics of serum HBsAg levels in Chinese patients with chronic hepatitis B based on CR-HepB]S Y Chen, S Shan, Y Y Kong, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|August 29, 2022
[Analysis of change in esophageal varices and clinical characteristics in hepatitis B virus-related cirrhosis after antiviral therapy]B Q Wang, X N Wu, J L Zhou, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 27, 2009
CYP2C9*1B promoter polymorphisms, in linkage with CYP2C19*2, affect phenytoin autoinduction of clearance and maintenance doseAmarjit S Chaudhry, Thomas J Urban, Jatinder K Lamba, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|August 29, 2022
[Histological regression and clinical benefits in patients with liver cirrhosis after long-term anti-HBV treatment]S Y Chen, Y M Sun, J L Zhou, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|October 30, 2025
[Analysis of factors affecting fibrosis reversal in patients with metabolic associated steatohepatitis based on magnetic resonance elastography]Z Y Zhang, C L Sun, H Ren, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|January 12, 2018
[Qualitative pathological assessment of liver fibrosis regression after antiviral therapy in patients with chronic hepatitis B]Y M Sun, J L Zhou, L Wang, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|May 9, 2017
[Efficacy and safety of pegylated interferon α-2b injection (Y shape, 40 kD) in treatment of patients with genotype 1/6 chronic hepatitis C]B Feng, J Shang, S H Wu, et al.
Pageof 36